QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 26.49

-3.3%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike Relyea who wrote (230)	11/25/1996 3:51:00 PM
From: Mike Relyea	of 1693

Monday November 25 12:26 PM EST P&G ( Procter & Gamble Co ) grants ulcer drug license to Glaxo Procter & Gamble granted a worldwide license to Glaxo Wellcome which allows Glaxo Wellcome to sell certain ulcer drug therapies.P&G will promote Helidac Therapy, which has an average wholesale price of $77.70, through health care professional magazine advertising and direct mail campaigns to physicians. biz.yahoo.com H. pylori testing sales are sure to increase with the promotion of the drug treatments. Will we see a marketing agreement for Quidel's H. pylori test between Quidel and Glaxo Wellcome? Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next